Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/12/2025

Evaluation and Management of Non-Ischemic Priapism

Diagnostic Approach

  • The American Urological Association recommends corporal blood gas analysis to distinguish between ischemic and non-ischemic priapism, as this fundamentally changes management urgency and approach 1, 2, 3
  • Ischemic priapism is characterized by PO₂ <30 mmHg, PCO₂ >60 mmHg, and pH <7.25, while non-ischemic priapism shows PO₂ >90 mmHg, PCO₂ <40 mmHg, and pH 7.40 1, 2, 3

Clinical Presentation

  • Non-ischemic priapism can persist for hours to weeks and is frequently recurrent, with nearly always non-painful and fully oxygenated corporal blood 4, 5
  • The glans and corpus spongiosum remain soft in both types of priapism, even when corpora cavernosa are rigid 1

Management

  • The European Association of Urology recommends observation for up to four weeks as initial management for non-ischemic priapism, as many fistulas close spontaneously resulting in penile detumescence 4, 2
  • Percutaneous fistula embolization is offered as first-line therapy if priapism persists after observation, with embolization resulting in penile detumescence in 85% of patients 4, 2

Treatment Outcomes

  • Embolization can be performed using both resorbable and non-resorbable materials with similar success rates 4
  • Immediate treatment with intracavernosal phenylephrine is indicated for ischemic priapism, although permanent erectile dysfunction is highly likely after 36 hours 6, 1

Critical Pitfalls to Avoid

  • Delaying corporal blood gas analysis can lead to delayed diagnosis and inappropriate treatment 1
  • Treating non-ischemic priapism as an emergency or performing aggressive interventions like aspiration/phenylephrine injection is unnecessary and potentially harmful 4, 3